Vise Technologies’s Pfizer PFE Stock Holding History

Vise Technologies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.42M	Hold	217,605	–	–	0.11%	161
2025 Q4	$5.42M	Buy	217,605 +63,386	+41%	+$1.6M	0.11%	161
2025 Q3	$3.93M	Sell	154,219 -77,413	-33%	-$1.91M	0.15%	141
2025 Q2	$5.61M	Buy	+231,632	New	+$5.4M	0.23%	94
2024 Q4	$2.01M	Buy	75,848 +7,759	+11%	+$210K	0.17%	132
2024 Q3	$1.97M	Buy	68,089 +16,637	+32%	+$485K	0.25%	88
2024 Q2	$1.44M	Buy	51,452 +4,476	+10%	+$123K	0.25%	90
2024 Q1	$1.3M	Sell	46,976 -7,897	-14%	-$219K	0.26%	86
2023 Q4	$1.58M	Sell	54,873 -13,208	-19%	-$399K	0.34%	76
2023 Q3	$2.26M	Buy	68,081 +2,955	+5%	+$104K	0.56%	42
2023 Q2	$2.39M	Buy	65,126 +835	+1%	+$32.5K	0.58%	39
2023 Q1	$2.62M	Buy	64,291 +16,304	+34%	+$704K	0.69%	33
2022 Q4	$2.46M	Buy	47,987 +8,044	+20%	+$386K	0.77%	27
2022 Q3	$1.75M	Buy	39,943 +13,379	+50%	+$650K	0.66%	33
2022 Q2	$1.39M	Buy	26,564 +11,205	+73%	+$571K	0.54%	40
2022 Q1	$795K	Buy	+15,359	New	+$797K	0.3%	83

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Vise Technologies's PFE Position: Q1 2026 in Review

Vise Technologies held its Pfizer (PFE) position steady in Q1 2026 at 217,605 shares worth $5.42M. The position accounts for 0.11% of the portfolio, ranked #161.

Vise Technologies first reported a position in PFE in Q1 2022 and has held it in 16 quarters since. The position peaked at $5.61M in Q2 2025. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Vise Technologies held 217,605 shares of Pfizer worth $5.42M as of Q1 2026.
Vise Technologies left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.11% of Vise Technologies's portfolio in Q1 2026, its #161 holding.
Vise Technologies first reported a position in Pfizer in Q1 2022 and has held it in 16 quarters since.
Vise Technologies's Pfizer position peaked at $5.61M in Q2 2025.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.